Details for Patent: 6,866,866
Summary for Patent: 6,866,866
| Title: | Controlled release metformin compositions |
| Abstract: | A composition for treating patients having non-insulin-dependent diabetes mellitus (NIDDM) by administering a controlled release oral solid dosage form containing preferably a biguanide drug such as metformin, on a once-a-day basis. The dosage form provides a mean time to maximum plasma concentration (Tmax) of the drug which occurs at 5.5 to 7.5 hours after oral administration on a once-a-day basis to human patients. Preferably, the dose of drug is administered at dinnertime to a patient in the fed state. |
| Inventor(s): | Chih-Ming Chen, Xiu-Xiu Cheng, Steve Jan, Joseph Chou |
| Assignee: | Andrx Laboratories LLC |
| Application Number: | US09/705,630 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,866,866 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Device; Dosage form; |
Drugs Protected by US Patent 6,866,866
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,866,866
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2005239716 | ⤷ Start Trial | |||
| Australia | 3083002 | ⤷ Start Trial | |||
| Brazil | 0115390 | ⤷ Start Trial | |||
| Canada | 2427195 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
